These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22270467)

  • 1. Evidence for using bisphosphonate to treat Legg-Calvé-Perthes disease.
    Young ML; Little DG; Kim HK
    Clin Orthop Relat Res; 2012 Sep; 470(9):2462-75. PubMed ID: 22270467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential for bisphosphonate treatment in Legg-Calve-Perthes disease.
    Little DG; Kim HK
    J Pediatr Orthop; 2011 Sep; 31(2 Suppl):S182-8. PubMed ID: 21857436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local administration of bone morphogenetic protein-2 and bisphosphonate during non-weight-bearing treatment of ischemic osteonecrosis of the femoral head: an experimental investigation in immature pigs.
    Kim HK; Aruwajoye O; Du J; Kamiya N
    J Bone Joint Surg Am; 2014 Sep; 96(18):1515-24. PubMed ID: 25232075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the evidence supporting the prevention of osteoarthritis and improved femoral coverage after shelf procedure for Legg-Calvé-Perthes disease?
    Hsu JE; Baldwin KD; Tannast M; Hosalkar H
    Clin Orthop Relat Res; 2012 Sep; 470(9):2421-30. PubMed ID: 22194022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D MRI Quantification of Femoral Head Deformity in Legg-Calvé-Perthes Disease.
    Standefer KD; Dempsey M; Jo C; Kim HKW
    J Orthop Res; 2017 Sep; 35(9):2051-2058. PubMed ID: 27864891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic effects of zoledronic acid in children with traumatic femoral head avascular necrosis and Legg-Calve-Perthes disease.
    Johannesen J; Briody J; McQuade M; Little DG; Cowell CT; Munns CF
    Bone; 2009 Nov; 45(5):898-902. PubMed ID: 19446052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low early failure rates using a surgical dislocation approach in healed Legg-Calvé-Perthes disease.
    Shore BJ; Novais EN; Millis MB; Kim YJ
    Clin Orthop Relat Res; 2012 Sep; 470(9):2441-9. PubMed ID: 22125243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Interleukin-6 Therapy Decreases Hip Synovitis and Bone Resorption and Increases Bone Formation Following Ischemic Osteonecrosis of the Femoral Head.
    Ren Y; Deng Z; Gokani V; Kutschke M; Mitchell TW; Aruwajoye O; Adapala NS; Kamiya N; Abu-Amer Y; Kim HK
    J Bone Miner Res; 2021 Feb; 36(2):357-368. PubMed ID: 33053220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local delivery of recombinant human bone morphogenetic proteins and bisphosphonate via sucrose acetate isobutyrate can prevent femoral head collapse in Legg-Calve-Perthes disease: a pilot study in pigs.
    Cheng TL; Murphy CM; Cantrill LC; Mikulec K; Carpenter C; Schindeler A; Little DG
    Int Orthop; 2014 Jul; 38(7):1527-33. PubMed ID: 24389948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RANKL inhibition: a novel strategy to decrease femoral head deformity after ischemic osteonecrosis.
    Kim HK; Morgan-Bagley S; Kostenuik P
    J Bone Miner Res; 2006 Dec; 21(12):1946-54. PubMed ID: 17002576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomechanical properties of bone and cartilage in growing femoral head following ischemic osteonecrosis.
    Koob TJ; Pringle D; Gedbaw E; Meredith J; Berrios R; Kim HK
    J Orthop Res; 2007 Jun; 25(6):750-7. PubMed ID: 17318897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does valgus femoral osteotomy improve femoral head roundness in severe Legg-Calvé-Perthes disease?
    Kim HT; Gu JK; Bae SH; Jang JH; Lee JS
    Clin Orthop Relat Res; 2013 Mar; 471(3):1021-7. PubMed ID: 23096935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology and new strategies for the treatment of Legg-Calvé-Perthes disease.
    Kim HK
    J Bone Joint Surg Am; 2012 Apr; 94(7):659-69. PubMed ID: 22488623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valgus femoral osteotomy for noncontainable Perthes hips: prognostic factors of remodeling.
    Yoo WJ; Choi IH; Moon HJ; Chang S; Cho TJ; Choi YH; Park MS; Chung CY
    J Pediatr Orthop; 2013 Sep; 33(6):650-5. PubMed ID: 23812133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retention, distribution, and effects of intraosseously administered ibandronate in the infarcted femoral head.
    Aya-ay J; Athavale S; Morgan-Bagley S; Bian H; Bauss F; Kim HK
    J Bone Miner Res; 2007 Jan; 22(1):93-100. PubMed ID: 17166092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging and early remodeling of the femoral head after femoral varus osteotomy in Legg-Calvé-Perthes disease.
    Eckerwall G; Hochbergs P; Wingstrand H; Egund N
    J Pediatr Orthop B; 1997 Oct; 6(4):239-44. PubMed ID: 9343781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Legg-Calvé-Perthes Disease: Diagnosis, Decision Making, and Outcome.
    Ng T; Liu R; Kulkarni VA
    Curr Sports Med Rep; 2024 Feb; 23(2):45-52. PubMed ID: 38315432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does transepiphyseal drilling and closure of the greater trochanter in early Legg-Calve-Perthes disease improve natural history?
    Eidelman M; Kotlarsky P
    Musculoskelet Surg; 2023 Sep; 107(3):279-285. PubMed ID: 35716245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Femoral Head Revascularization in Legg-Calvé-Perthes Disease Using Serial Perfusion MRI.
    Kim HK; Burgess J; Thoveson A; Gudmundsson P; Dempsey M; Jo CH
    J Bone Joint Surg Am; 2016 Nov; 98(22):1897-1904. PubMed ID: 27852906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do femoral or salter innominate osteotomies improve femoral head sphericity in Legg-Calvé-Perthes disease? A meta-analysis.
    Saran N; Varghese R; Mulpuri K
    Clin Orthop Relat Res; 2012 Sep; 470(9):2383-93. PubMed ID: 22467420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.